Abstract
The evidence of symptomatic vesico-ureteral reflux after kidney transplant impose its correction. In our experience the incidence of this correction is 1%. The first choice is endoscopes treatment with periorifitial injections (75% good results) with Teflon or Macroplastique. In the latest four patients with symptomatic vesico-ureteral reflux III degree (recurrent urinary infections, serum creatinina >20–40%) we applied Coaptite®, with three periorifitial injections. Coaptite® is a biocompatible material, natural and inert, made of calcium idrossiapatite spheres of 100 micron suspended in a water and glycerine gel. These characteristics made Coaptite® much more suitable in transplanted patients with immunosuppressive therapy. Coaptite® is X-ray opaque: treatments and results are more easily measurable. The results with Coaptite® are superimposable to Teflon or Macroplastique. We observed any complications.
Get full access to this article
View all access options for this article.